Pandrug-resistant isolate of Klebsiella pneumoniae causes less damage than drug-susceptible isolates in a rabbit model Abstract Purpose: Bacterial infections induce a series of in ammatory responses and lead to longer hospital stays and increased mortality. In clinical work, we o en nd that infections caused by drug-susceptible isolates have a worse outcome than those caused by pandrug-resistant isolates. To goal of this study was to assess the impact of drug resistant in a rabbit model of Klebsiella pneumoniae infection.
Bacterial infections cause mild to life-threatening illnesses through activation of a series of proin ammatory, antiin ammatory and apoptotic cascades that ultimately result in a disruption of physiologic homeostasis [1] [2] [3] [4] [5] . Some studies have concluded that patients infected with bacteria susceptible to drug treatment had a better outcome than did patients infected with multidrug-resistant bacteria [6, 7] . Other studies by Giamarellos-Bourboulis and Bristianou showed that rabbits infected with drug susceptible strains of E. coli had worse outcomes than those infected with multidrug-resistant strains, and cytokine release patterns were di erent [8] [9] [10] . Glauser suggested that multidrug-resistant isolates might interfere with the mechanism leading to sepsis, resulting in lower pathogenicity [11] . Recently, due to the development of pandrugresistance bacterial strains, this controversy has become more complicated; however, there are no clear data regarding the extent to which pandrug-resistance bacteria in uences mortality of patients. In order to con rm the di erences among susceptible, multidrug-resistant and pandrug-resistance isolates, we established a rabbit model of experimental bacteremia simulating central venous catheter infection caused by Klebsiella pneumoniae. Plasma cytokine release and survival following in ammatory response was assessed.
Animals and Methods
A total of 30 New Zealand rabbits of mean (± standard deviation) weight 3.32 ± 0.54 kg were used. Animals were housed in a speci c pathogen-free room within the animal care facility, given free access to tap water and standard balanced rabbit chow. Animals were housed under 12-h light/dark cycles. e study was approved by the Institutional Animal Care and Use Committee of Nanjing University and the Principles of Laboratory Animal Care were followed. ree blood culture isolates of Klebsiella pneumoniae were used. One isolate was susceptible (A), one multidrug-resistant (B) and one pandrug-resistant (C). All were derived from patients with nosocomial infections. Pulsed eld gel electrophoresis (PFGE) was used to analysis the genetic relatedness of the clinical isolates A, B, and C: little genetic variation among the three isolates was seen. Resistance to two or more groups of antimicrobials with di erent chemical structure was de ned as multidrug-resistant. Resistance to all antimicrobials was dened as pandrug-resistant. Minimal inhibitory concentrations (MICs) were determined according to the Clinical and Laboratory Standards Institute (CLSI) procedures. For the drug susceptible isolate A, MICs to amoxicillin/clavulanate, piperacillin, ce azidime, cipro oxacin, amikacin, imipenem and colistin were 4/4, 8, 4, 1, 2, 2 and 1 mg/L, respectively. For the multidrug-resistant isolate B, MICs were 128/4, 256, 64, 2, 64, 4 and 1 mg/L, respectively. For the pandrug-resistant isolate C, MICs were >256/4, >512, >256, >128, >256, >256, and 2 mg/L, respectively. As determined by disk di usion method, including the Ce azidime and Ce azidime-clavulanic acid, isolate A was extended-spectrum beta-lactamase (ESBL) negative and isolates B and C were ESBL positive.
e drugresistance gene of SHV was tested for using polymerase chain reaction (PCR) with the following primers: SHV5' 5' GGG TTA TTC TTA TTT GTC GC 3' and SHV3' 5'TTA GCG TTG CCA GTG CTC 3' (928bp) and this gene was found to be present in isolate B and C.
e bacterial concentration was determined by measuring absorbance at 600 nm and compared to a predetermined standard curve. Bacteria were then diluted to the desired concentration for inoculation.
Rabbits were sedated by intramuscular injection of 20 mg/kg of ketamine. Anesthesia was maintained by intravenous administration of 20 mg/kg of lidocaine at 20 min intervals. No analgesics were used, as the operation was brief. A 2 cm-long midline incision was made on the neck to expose the right inner jugular vein [8, 9] . An 18G catheter was inserted and 1 × 10 8 colony forming units (cfu) per kg of the prepared K. pneumoniae isolate was injected, in a volume of 2.0 mL. Just prior to the bacterial injection and at 1, 3, 24, 72 and 120 h a er bacterial challenge, 3 mL of blood was taken from an ear vein. Of the blood samples, one mL was used for analysis of leukocyte counts and for determination of tumor necrosis factor-alpha (TNFα), interleukin (IL-17) and high mobility group box 1 (HMGB1) levels. e remaining 2 mL were immediately centrifuged at 2000 rpm for 10 min, serum was collected, frozen and kept at -70 °C until cytokine analysis was performed. e catheter was removed and the incision was ligated. During the experiment, no antibiotic was used. For survival studies, rabbits intravenously inoculated with bacteria were monitored twice daily (morning and late a ernoon) for signs of illness. Animals were monitored for 14 days a er which all surviving animals were sacri ced. Under sterile conditions, segments from the liver, spleen and lower lobe of the right lung were taken for subsequent bacterial quantitation.
For organ bacterial counts, a small aliquot of tissue homogenate was serially diluted, plated on blood agar plates and incubated at 37 °C. A er 24 h, colonies were counted by operators who were blinded to the di erent treatment groups. Results are expressed as log 10 of cfu per milliliter.
α Plasma levels of TNFα, IL-17, and HMGB-1 were determined by enzyme-linked immunosorbent assay (ELISA) using commercially available kits that are selective for rabbit cytokines (Adlitteram Diagnostic Laboratories, USA). Manufacturer's directions were followed. e minimum detectable concentrations were 0.5 pg/mL for TNFα, one pg/mL for IL-17, and one ng/mL for HMGB-1.
Comparisons of serum concentration-time curves of each parameter between animals infected by the three isolates were performed by multiple regression analysis. Comparisons between di erent times of sampling were performed by one-way analysis of variance. Survival of animals infected by each isolate was estimated by Kaplan-Meier analysis. Comparisons of survival a er challenge by each isolate were performed by the logrank test. Correlation between the number of viable cells in various organs and survival was performed by linear regression analysis. Probability (p) values less than 0.05 were considered signi cant.
Results
Death occurred in seven rabbits a er infection with isolate A (mortality rate 70%); rabbits had a mean survival time of 10.5 ± 3.63 days. Rabbits infected with isolate B had a mortality rate of 30% and the mean survival time was 12.7 ± 2.31 days.
e mortality rate of rabbits infected with isolate C was only 10% and these animals had a mean survival time of 13.9 ± 0.32 days (for isolate A vs. C, p < 0.004) (Fig. 1) .
Leukocytes decreased dramatically at one and 3 h a er K. pneumoniae injection in all three groups, compared to the value just prior to infection. Rabbits challenged with isolate A clearly had more severe in ammatory reactions ( Fig. 2A) . At 24 h post-infection, leukocyte levels in rabbits challenged with isolate A were signi cantly higher than in rabbits challenged with B or C (for isolate A vs. C, p < 0.002).
Di erences in cytokine levels were also observed among the groups. e signi cantly higher plasma level of TNFα in group A animals compared to those in groups B and C (p values?) likely contributed to the increased mortality of these animals ( Fig. 2B) . TNFα increased to similar levels; however, over time, the levels in animals infected with isolates B and C were lower than levels in animals infected with isolate A (for isolate A vs. B, p < 0.001; for isolate A vs. C, p < 0.001). Within one h of infection, signi cant induction of IL-17 was observed (Fig. 2C) . At 3 h, levels of IL-17 peaked. Concentrations of IL-17 in animals infected with isolate A were higher than those infected with isolates B and C (for isolate A vs. B, p < 0.015; for isolate A vs. C, p < 0.001). Di erences in serum IL-17 levels between rabbits challenged by isolates B and C were not signi cant. Unlike levels of TNFα and IL-17, HMGB-1 levels in plasma did not peak until 24 h post-infection (Fig. 2D) . Concentrations of HMGB-1 were lower in animals challenged with isolates B and C than A (for isolate A vs. B, p < 0.001; for isolate A vs. C, p < 0.001).
To determine if infection with pandrug-resistant bacteria results in a reduced bacterial load compared with infection with a drug-susceptible strain, blood and tissue samples taken from animals either at the time of death or on day 14 were analysed. e results of bacterial blood counts are shown in Fig.  2E . Bacterial blood counts in animals infected with isolates A and B were signi cantly higher than those of animals infected with isolate C (for isolate A vs. B, p < 0.005; for isolate A vs. C, p < 0.001). ere was detectable growth of bacterial colonies from tissue samples taken from some animals in all the three experimental groups; however, there was no detectable growth of bacteria from certain rabbits challenged with isolate C (Fig. 3) .
Discussion
e increasing numbers of pandrug-resistant bacterial strains is particularly prevalent in nosocomial infections worldwide. To counteract this worrisome situation, a more thorough understanding of infection resulting from exposure to pandrugresistant bacterial strains is appropriate. e present study was designed to provide some answers regarding the impact of pandrug-resistant on the host. ree di erent strains of K. pneumoniae were used in the bacteremia model: one isolate that was susceptible to all antimicrobials tested (isolate A), one multidrug-resistant isolate with moderate MIC values (isolate B) and one pandrug-resistant isolate with high MIC values (isolate C). Rabbits infected with the susceptible K. pneumoniae isolate (A) had a markedly enhanced leukocyte and cytokine response and higher mortality than rabbits infected with drug-resistant strains (B and C). Animals infected with isolate C had lower mortality and bacterial load than animals in the other two groups. To the best of our knowledge, this is the rst report demonstrating di erences in the mechanism of bacteremia by susceptible and pandrug-resistant K. pneumoniae.
Leukocytes are an integral component of response to infection. Some studies have found that patients with higher leukopenic or leukemoid responses to infection have worse outcomes than patients that do not mount as intense a response [12, 13] . In our study, a er K. pneumoniae infection of rabbits, leukocyte levels increased in all three groups and peaked at 24 h. Animals treated with the susceptible isolate had signicantly higher leukocyte levels than animals in the other two groups. us, the higher virulence of isolate A was associated with an increased in ammatory response.
Plasma levels of TNFα, IL-17, and HMGB-1 were also measured. TNFα is a peptide mediator released by monocytes and macrophages in response to various stimuli, including bacterial lipopolysaccharides [14] . Overproduction of TNFα is associated with a wide range of pathologic conditions [15] . Marcin found that in rats with cecal ligation and puncture (CLP), plasma levels of TNFα (12 ng/ml) accurately predicted mortality within 24 h [16] . In our study, 3 h a er infection with the susceptible K. pneumoniae isolate, TNFα levels in plasma rose to a higher level than did plasma levels in the other two groups.
IL-17 is a T cell-derived proin ammatory cytokine that is involved in accumulation and activation of neutrophils [17, 18] . IL-17 receptor-de cient mice infected intranasally with K. pneumoniae have increased numbers of recoverable bacteria in the lung, increased bacterial dissemination into the spleen, and reduced overall survival [19] . In sepsis triggered by CLP, IL-17 neutralization improves survival and is associated with signicant reductions in bacteremia and systemic cytokine production [20] . In our experiment, an increase of plasma IL-17 levels 3 h post-infection was observed, with higher levels in the susceptible isolate group.
HMGB1 is released by endotoxin-activated macrophages/ monocytes and functions as a late mediator of lethal endotoxemia and sepsis [21] . Circulating HMGB1 levels are elevated in animals between 16 and 32 h a er onset of endotoxemia or sepsis and in patients with sepsis [21, 22] or hemorrhagic shock [23] .
, HMGB1 can induce production of TNF and IL-1 by macrophages, monocytes, and neutrophils in a p38 MAPK-dependent mechanism. Plasma HMGB1 levels reached a peak at 24 h, with animals in the drug-susceptible group having higher levels than the animals in the pandrugresistant groups.
In conclusion, rabbits infected with a pandrug-resistant isolate of K. pneumoniae survived longer and had a lower in ammatory response than did animals infected with drugsusceptible isolates. An explanation of the animal ndings appears to be the di erent growth rate of bacteria in blood and tissues. e second hypothesis is that some antibiotics may induce the loss of virulence factors contained in pathogenicity islands (PAIs) of the prokaryotic genome. Further studies will be required to clarify these ndings.
